Aristotle University Of Thessaloniki (AUTH)
Η επίδραση του Imatinib Mesylate στη επούλωση των αναστομώσεων παχέος εντέρου: πειραματική μελέτη σε επιμύες
Abstract
dc:descriptionLarge bowel operations often include by an end-to-end anastomosis in order to maintain the continuity of the peptic system. Leakage of colonic anastomosis is a serious postoperative complication that increases morbidity and mortality rates. Several drugs that have been studied were found to have negative impact on the anastomotic integrity. Imatinib mesylate is a new chemotherapeutic agent which is used against chronic myelogenous leukemia and gastrointestinal stromal tumors. Aim of this experimental study was to investigate the possible negative effect of Imatinib mesylate on the colonic anastomosis. Sixty Wistar rats were divided into two groups of thirty animals each group. The study group was given 50 mg/Kg BW/d Imatinib by gavage starting one-week prior the operation and throughout the experiment. Placebo was administered to the control group in equal amounts. Both groups underwent an end-to-end colon anastomosis. They were further subdivided into subgroups of ten animals each and were sacrificed on the 3d, 7th and 14th postoperative day. The mechanical strength of the anastomosis was assessed by measuring the bursting pressure. The anastomoses were also examined macroscopically and microscopically by the electronic microscope. The serum levels of IL-2, IL-6 and TNF-a were measured in all animals. The findings of the two groups were compared by using Mann-Whitney test. Our results indicate that Imatinib mesylate impairs the integrity of colon anastomosis especially during the inflammatory phase. The negative effects of the drug were minimal of the subgroup that was sacrificed on the 7th p.o day and no differences were found between study and control groups of the 14th p.o. day. We believe that these results could to be the outcome of tPDGFR inhibition by Imatinib mesylate. PDGF is known to be an activator of cells that play an important role in the early phases of wound healing. It is responsible for the recruitment, proliferation and gene expression in macrophages, lymphocells and fibroblasts. Based on results of this experimental study, we could claim that Imatinib mesylate has a negative effect on large bowel anastomosis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Aimoniotou-Georgiou, Eleni
- Αιμονιώτου-Γεωργίου, Ελένη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19505